Cleared Traditional

K926396 - ADRENOCORTICOTROPIC/ACTH ANALYSIS PRODUCT

K926396 is an FDA 510(k) clearance for ADRENOCORTICOTROPIC/ACTH ANALYSIS PRODUCT, manufactured by Nichols Institute. The device is a Class 2 Chemistry device with product code CKG cleared through the Traditional 510(k) pathway after a 218-day FDA review.

K926396 · Nichols Institute · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1993
Decision
218d
Days
Class 2
Risk

K926396 is an FDA 510(k) clearance for the ADRENOCORTICOTROPIC/ACTH ANALYSIS PRODUCT. Classified as Radioimmunoassay, Acth (product code CKG), Class II - Special Controls.

Submitted by Nichols Institute (San Juan Capistrano, US). The FDA issued a Cleared decision on July 27, 1993 after a review of 218 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1025 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Nichols Institute devices

FDA 510(k) Submission Details - K926396

510(k) Number K926396 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 21, 1992
Decision Date July 27, 1993
Days to Decision 218 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
130d slower than avg
Panel avg: 88d · This submission: 218d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CKG Device Classification - Class 2, Special Controls

Product Code CKG Radioimmunoassay, Acth
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1025
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CKG Radioimmunoassay, Acth

All 21
Devices cleared under the same product code (CKG) and FDA review panel - the closest regulatory comparables to K926396.
MICRO HAEMATOCRIT CENTRIFUGE
K960491 · Hawksley & Sons , Ltd. · Oct 1996
IMMULITE ACTH
K960066 · Diagnostic Products Corp. · Feb 1996
INCSTAR ACTH IRMA
K940271 · Incstar Corp. · Aug 1994
MODIFIED DSL-2300 ACTH RIA
K900147 · Diagnostic Systems Laboratories, Inc. · Mar 1990
ALLEGRO ACTH IMMUNOASSAY KIT 65 AND 130 TUBES
K882741 · Nichols Institute Diagnostics · Aug 1988
ACTH II BY RADIOIMMUNOASSAY
K850882 · Immuno Nuclear Corp. · Mar 1985